Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis

Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis

<p dir="ltr">Meningiomas are the most prevalent primary intracranial tumors. The majority are benign but can undergo dedifferentiation into advanced grades classified by World Health Organization (WHO) into Grades 1 to 3. Meningiomas’ tremendous variability in tumor behavior and slow...

Full description

Saved in:
Bibliographic Details
Main Author: Reem Halabi (22482097) (author)
Other Authors: Fatima Dakroub (13014998) (author), Mohammad Z. Haider (5429717) (author), Stuti Patel (3899836) (author), Nayef A. Amhaz (22482098) (author), Mohammad A. Reslan (22482102) (author), Ali H. Eid (5461829) (author), Yehia Mechref (17849097) (author), Nadine Darwiche (12223496) (author), Firas Kobeissy (17849094) (author), Ibrahim Omeis (11496641) (author), Abdullah Shaito (20545181) (author)
Published: 2023
Subjects:
Biological sciences
Biochemistry and cell biology
Genetics
Biomedical and clinical sciences
Medical biochemistry and metabolomics
Neurosciences
Oncology and carcinogenesis
meningioma
NF2 mutations
biomarker
miRNA
proteomics
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items